These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2300020)

  • 1. Actuarial predictions from population-based disease registries with unidentified random losses.
    Tallis GM; Leppard P; O'Neill TJ
    Med J Aust; 1990 Feb; 152(3):167-8. PubMed ID: 2300020
    [No Abstract]   [Full Text] [Related]  

  • 2. Conditioned life tables from registries with unidentified random losses.
    Tallis GM; Leppard P; O'Neill TJ
    Stat Med; 1993 Apr; 12(8):767-75. PubMed ID: 8516593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The analysis of survival data from a central cancer registry with passive follow-up.
    Tallis GM; Leppard P; O'Neill TJ
    Stat Med; 1988 Apr; 7(4):483-90. PubMed ID: 3368675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphoma incidence, cyclosporine, and the evolution and major impact of malignancy following organ transplantation.
    Sheil AG; Disney AP; Mathew TH; Livingston BE; Keogh AM
    Transplant Proc; 1997; 29(1-2):825-7. PubMed ID: 9123543
    [No Abstract]   [Full Text] [Related]  

  • 5. The prevalence of cancer--Connecticut, January 1, 1982.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1987 Apr; 36(13):205-7. PubMed ID: 3104757
    [No Abstract]   [Full Text] [Related]  

  • 6. The South Australian Cancer Registry: a means of assessing cancer incidence, mortality and case survival.
    Bonett A; Roder D; Milliken L
    Eur J Cancer; 1992; 28A(11):1923-6. PubMed ID: 1389537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leads from the MMWR. The prevalence of cancer--Connecticut, January 1, 1982.
    JAMA; 1987 May; 257(17):2272-3. PubMed ID: 3573224
    [No Abstract]   [Full Text] [Related]  

  • 8. Rising incidence of hepatitis B-related hepatocellular carcinoma in South Australia: 1996-2010.
    Chinnaratha MA; Graham C; Fraser RJ; Woodman RJ; Wigg AJ
    Intern Med J; 2016 Aug; 46(8):902-8. PubMed ID: 27130077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival predictions of amalgam restorations.
    Smales RJ; Webster DA; Leppard PI
    J Dent; 1991 Oct; 19(5):272-7. PubMed ID: 1806592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer and cancer risk in South Australia: what evidence for a rural-urban health differential?
    Wilkinson D; Cameron K
    Aust J Rural Health; 2004 Apr; 12(2):61-6. PubMed ID: 15023223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer registry data: actuarial survival estimation in lung cancer patients.
    Vích Z
    Neoplasma; 1988; 35(2):129-33. PubMed ID: 3374703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer registration: principles and methods. Analysis of survival.
    Parkin DM; Hakulinen T
    IARC Sci Publ; 1991; (95):159-76. PubMed ID: 1894319
    [No Abstract]   [Full Text] [Related]  

  • 13. Scleroderma in South Australia: further epidemiological observations supporting a stochastic explanation.
    Roberts-Thomson PJ; Walker JG; Lu TY; Esterman A; Hakendorf P; Smith MD; Ahern MJ
    Intern Med J; 2006 Aug; 36(8):489-97. PubMed ID: 16866652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss-adjusted hospital and population-based survival of cancer patients.
    Ganesh B; Swaminathan R; Mathew A; Sankaranarayanan R; Hakama M
    IARC Sci Publ; 2011; (162):15-21. PubMed ID: 21675402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scleroderma in South Australia: epidemiological observations of possible pathogenic significance.
    Roberts-Thomson PJ; Jones M; Hakendorf P; Kencana Dharmapatni AA; Walker JG; MacFarlane JG; Smith MD; Ahern MJ
    Intern Med J; 2001; 31(4):220-9. PubMed ID: 11456035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blindness and trachoma in South Australia.
    Graham P
    Aust N Z J Ophthalmol; 1996 May; 24(2):161-2. PubMed ID: 9199751
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk of cancer in patients with scleroderma: a population based cohort study.
    Hill CL; Nguyen AM; Roder D; Roberts-Thomson P
    Ann Rheum Dis; 2003 Aug; 62(8):728-31. PubMed ID: 12860727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The coverage of cancer patients by designated palliative services: a population-based study, South Australia, 1999.
    Hunt RW; Fazekas BS; Luke CG; Priest KR; Roder DM
    Palliat Med; 2002 Sep; 16(5):403-9. PubMed ID: 12380658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring contrary trends in bladder cancer incidence, mortality and survival: implications for research and cancer control.
    Luke C; Tracey E; Stapleton A; Roder D
    Intern Med J; 2010 May; 40(5):357-62. PubMed ID: 19460053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing cancer profiles and survival of aboriginal and non-aboriginal patients in South Australia: where are the opportunities for improving Aboriginal health?
    Cottrell J; Street J; Chong A; Roder D
    Asian Pac J Cancer Prev; 2007; 8(4):495-501. PubMed ID: 18260718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.